Drugs Payment Scheme

Dáil Éireann Debate, Tuesday - 2 May 2017

Tuesday, 2 May 2017

Questions (1061)

Eamon Scanlon

Question:

1061. Deputy Eamon Scanlon asked the Minister for Health the position regarding making the immunotherapy drug nivolumab available to cancer patients on the reimbursement scheme; the costs associated with treating each person on an annual basis; and if he will make a statement on the matter. [20390/17]

Written answers

Minister for Health

The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.